Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Dyson

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Plos Genetics|August 24, 2012
It's all in the timing: too much E2F is a bad thingBrandon N Nicolay, Nicholas J Dyson
Oncogene|April 20, 2005
The E2F transcriptional network: old acquaintances with new facesDesssislava K Dimova, Nicholas J Dyson
Molecular & Cellular Oncology|June 17, 2016
Pumilio and nanos RNA-binding proteins counterbalance the transcriptional consequences of RB1 inactivationWayne O Miles, Nicholas J Dyson
Cell Cycle (Georgetown, Tex.)|May 21, 2011
The complex roles of histone demethylases in vivoLuisa Di Stefano, Nicholas J Dyson
Biomolecular Concepts|December 2, 2014
The emerging roles for histone demethylases in the modulation of signaling pathwaysLuisa Di Stefano, Nicholas J Dyson
Nature Reviews. Molecular Cell Biology|August 23, 2008
Conserved functions of the pRB and E2F familiesSander van den Heuvel, Nicholas J Dyson
Cell Cycle (Georgetown, Tex.)|May 4, 2023
Seeing is believing: the impact of RB on nuclear organizationBadri Krishnan, Ioannis Sanidas, Nicholas J Dyson
Genes & Development|June 5, 2012
Phosphorylation puts the pRb tumor suppressor into shapeAndreas M F Heilmann, Nicholas J Dyson
Trends in Cell Biology|August 30, 2023
Patterns in the tapestry of chromatin-bound RBIoannis Sanidas, Michael S Lawrence, Nicholas J Dyson
Cancer Research|January 10, 2002
Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signalingArnab Chakravarti, Jay S Loeffler, Nicholas J Dyson
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Plos Genetics|August 24, 2012
It's all in the timing: too much E2F is a bad thingBrandon N Nicolay, Nicholas J Dyson
Oncogene|April 20, 2005
The E2F transcriptional network: old acquaintances with new facesDesssislava K Dimova, Nicholas J Dyson
Molecular & Cellular Oncology|June 17, 2016
Pumilio and nanos RNA-binding proteins counterbalance the transcriptional consequences of RB1 inactivationWayne O Miles, Nicholas J Dyson
Cell Cycle (Georgetown, Tex.)|May 21, 2011
The complex roles of histone demethylases in vivoLuisa Di Stefano, Nicholas J Dyson
Biomolecular Concepts|December 2, 2014
The emerging roles for histone demethylases in the modulation of signaling pathwaysLuisa Di Stefano, Nicholas J Dyson
Nature Reviews. Molecular Cell Biology|August 23, 2008
Conserved functions of the pRB and E2F familiesSander van den Heuvel, Nicholas J Dyson
Cell Cycle (Georgetown, Tex.)|May 4, 2023
Seeing is believing: the impact of RB on nuclear organizationBadri Krishnan, Ioannis Sanidas, Nicholas J Dyson
Genes & Development|June 5, 2012
Phosphorylation puts the pRb tumor suppressor into shapeAndreas M F Heilmann, Nicholas J Dyson
Trends in Cell Biology|August 30, 2023
Patterns in the tapestry of chromatin-bound RBIoannis Sanidas, Michael S Lawrence, Nicholas J Dyson
Cancer Research|January 10, 2002
Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signalingArnab Chakravarti, Jay S Loeffler, Nicholas J Dyson
Pageof 8